Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Capsella" patented technology

Capsella is a genus of herbaceous plant and biennial plants in the mustard family Brassicaceae. It is a close relative of Arabidopsis, Neslia, and Halimolobos. Some recent authors circumscribe Capsella to contain only three species: Capsella bursa-pastoris, Capsella rubella and Capsella grandiflora.

A firming, brightening, soothing composition and use thereof

This invention belongs to the field of cosmetic technology, specifically relating to a firming, brightening, and soothing composition and its application. The firming, brightening, and soothing composition provided by this invention is a compound of *Palmaria rubra* bark extract, *Capsella bursa-pastoris* fruit extract, *Saururus chinensis* extract, and bakuchiol. These four ingredients synergistically promote the transdermal absorption of active ingredients, achieving firming, brightening, and soothing effects. Furthermore, this composition is gentle and non-irritating, and its preparation method is simple, making it feasible for industrialization. The composition provided by this invention has a wide range of applicability in skincare products. Its preparation method for serums is simple and easy to operate, and the prepared serums have firming, brightening, and soothing effects. Moreover, patch tests show that the serums are gentle and non-irritating, indicating that the composition of this invention has broad market application value in skincare products.
Owner:DOCTOR PLANT GUANGDONG BIOTECHNOLOGY CO LTD

Traditional Chinese medicine composition for treating ulcerative colitis

This invention provides a traditional Chinese medicine composition for treating ulcerative colitis, belonging to the field of traditional Chinese medicine pharmaceutical technology. The composition is obtained through rational formulation based on the principles of syndrome differentiation and treatment in traditional Chinese medicine, specifically composed of Forsythia suspensa, Lilium brownii, Lysimachia christinae, Sesamum indicum, Prickly ash, Pueraria lobata, Centella asiatica, Viola yedoensis, Houttuynia cordata, Portulaca oleracea, Litsea cubeba, Cirsium japonicum, Schizonepeta tenuifolia, Morus alba root, Lophatherum gracile, Lygodium japonicum, and Capsella bursa-pastoris. This invention's composition exhibits significant anti-inflammatory and de-inflammatory effects, and can repair and improve the integrity of colonic tissue structure, enhance intestinal barrier function, and achieve both symptomatic and root-cause treatment of ulcerative colitis. Simultaneously, this invention's composition has a high efficacy and cure rate in treating ulcerative colitis, and significantly alleviates symptoms such as diarrhea, bloody stools, abdominal pain, abdominal distension, anal burning, and tenesmus, greatly reducing patient suffering.
Owner:HENAN UNIV OF CHINESE MEDICINE

Yarrowia lipolytica genetically engineered bacteria and application thereof

ActiveCN116396875BFungiBiofuelsNervonic acidRapeseed
This invention provides a genetically engineered *Yersinia lipolytica* strain and its applications. The genetically engineered strain is a *Yersinia lipolytica* Po1f strain with the PEX10 gene knocked out, expressing the C16 / 18 elongase gene MaELO3 from *Morchella alpina*, the elongase gene AtKCS from *Arabidopsis thaliana*, and the elongase gene CraKCS from *Brassica oleracea*. The strain also expresses the elongase gene CgKCS from *Capsella*. Further expression of the desaturase gene MaD15D from *Morchella alpina*, and overexpression of the strain's own diacylglycerol transferase gene DGA1 and its own Δ9 desaturase gene OLE1, resulted in a nervonic acid yield of 111.6 mg / L in shake-flask fermentation. By adding 1% rapeseed oil exogenously, the nervonic acid yield reached 185.1 mg / L. The *Yersinia lipolytica* genetically engineered strain constructed in this invention is simple to operate, has stable and reliable performance, and can be applied to large-scale commercial production.
Owner:EAST CHINA UNIV OF SCI & TECH

Arabidopsis pollen distant signal gene AtSIPS and application thereof

The invention discloses an arabidopsis pollen distant signal gene AtSIPS and application thereof, and belongs to the technical field of plant genetic engineering. The invention discloses an arabidopsis pollen distant signal gene AtSIPS and an application of a protein coded by the arabidopsis pollen distant signal gene AtSIPS in regulation and control of distant hybridization reproductive disorder ability of cruciferous plants. The gene has nucleotide sequences shown as SEQ ID No.1 and SEQ ID No.2. According to the invention, it is found for the first time that the AtSIPS gene is a distant signal in arabidopsis pollen, and the distant signal gene AtSIPS of the arabidopsis pollen is edited in a targeted manner in Col-0 ecological arabidopsis thaliana by using a CRISPR / Cas9 gene editing technology, so that an atsips1 / atsips2 mutant plant is obtained. The invention has the following advantages and positive effects: (1) the AtSIPS gene is determined as a distant signal in the arabidopsis pollen for the first time; (2) the mutant pollen with the AtSIPS gene knocked out can germinate and grow on capsella bursa-pastoris stigmas, and hybrid ovules are obtained; (3) the discovery of the gene perfects the distant hybridization molecular mechanism of the cruciferous plants, and provides a new idea for transferring ideal characters of wild relative species into the cruciferous plants in the future.
Owner:SHANDONG AGRICULTURAL UNIVERSITY